Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Rev. méd. Chile ; 147(2): 256-260, Feb. 2019. graf
Article in English | LILACS | ID: biblio-1004341

ABSTRACT

ABSTRACT Adenovirus (ADV) is a recognized cause of severe disease among immunocompromised patients. We report a previously healthy 39-year-old female, admitted with influenza pneumonia and evolving with lung hemorrhage and acute renal failure requiring mechanical ventilation and hemodialysis. She received high corticosteroid doses due to an initial suspicion of alveolar hemorrhage. Lymphopenia already present before steroid use (567/μL), was maintained during the whole hospital stay (mean 782/μL). From the second week of admission she presented a high-volume diarrhea (mean 2.5 L/day) associated to intermittent bloody stools. An ulcerative enterocolitis was confirmed by CT images and colonoscopy. ADV was detected in a colonic tissue sample by real time PCR but not by a commercial filmarray test. Cidofovir-probenecid and racecadotril therapy were indicated without changing the clinical course of diarrhea and the patient finally died.


Adenovirus (ADV) es una causa reconocida de enfermedades graves en pacientes inmunocomprometidos. Informamos el caso de una mujer de 39 años, previamente sana, que ingresó por neumonía grave por influenza, evolucionando con hemorragia pulmonar y falla renal aguda, requiriendo ventilación mecánica y hemodiálisis. Recibió altas dosis de corticoides por la sospecha inicial de una hemorragia alveolar. Tuvo linfopenia durante toda su estadía (promedio 782/μL), la que ya estaba presente antes del uso de los corticoides (567/μL). Desde la segunda semana de hospitalización, presentó una diarrea de alto volumen (promedio 2,5 L/día) asociada a la presencia de sangre en deposiciones en forma intermitente. Se confirmó una enterocolitis ulcerativa por tomografía computada y colonoscopía. Se detectó ADV en muestras de biopsia colónica por PCR en tiempo real pero no por un test de PCR múltiples automatizado comercial. Fue tratada con cidofovir-probenecid y racecadrotrilo sin impacto clínico y la paciente finalmente falleció.


Subject(s)
Humans , Female , Adult , Cross Infection/etiology , Immunocompromised Host , Adenoviridae Infections/complications , Enterocolitis/etiology , Gastrointestinal Hemorrhage/etiology , Adenoviridae/isolation & purification , Cross Infection/diagnosis , Cross Infection/immunology , Fatal Outcome , Adenoviridae Infections/microbiology , Diarrhea/complications , Enterocolitis/diagnosis , Enterocolitis/immunology , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/immunology
2.
Braz. j. infect. dis ; 19(1): 58-61, Jan-Feb/2015. graf
Article in English | LILACS | ID: lil-741233

ABSTRACT

Background: Vancomycin-resistant enterococci colonization has been reported to increase the risk of developing infections, including bloodstream infections. Aim: In this study, we aimed to share our experience with the vancomycin-resistant enterococci bloodstream infections following gastrointestinal vancomycin-resistant enterococci colonization in pediatric population during a period of 18 months. Method: A retrospective cohort of children admitted to a 400-bed tertiary teaching hospital in Izmir, Turkey whose vancomycin-resistant enterococci colonization was newly detected during routine surveillances for gastrointestinal vancomycin-resistant enterococci colonization during the period of January 2009 and December 2012 were included in this study. All vancomycin-resistant enterococci isolates found within 18 months after initial detection were evaluated for evidence of infection. Findings: Two hundred and sixteen patients with vancomycin-resistant enterococci were included in the study. Vancomycin-resistant enterococci colonization was detected in 136 patients (62.3%) while they were hospitalized at intensive care units; while the remaining majority (33.0%) were hospitalized at hematology-oncology department. Vancomycinresistant enterococci bacteremia was present only in three (1.55%) patients. All these patients were immunosuppressed due to human immunodeficiency virus (one patient) and intensive chemotherapy (two patients). Conclusion: In conclusion, our study found that 1.55% of vancomycin-resistant enterococcicolonized children had developed vancomycin-resistant enterococci bloodstream infection among the pediatric intensive care unit and hematology/oncology patients; according to our findings, we suggest that immunosupression is the key point for developing vancomycinresistant enterococci bloodstream infections. .


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Bacteremia/microbiology , Cross Infection/microbiology , Gram-Positive Bacterial Infections/microbiology , Vancomycin-Resistant Enterococci , Bacteremia/epidemiology , Bacteremia/immunology , Cohort Studies , Cross Infection/epidemiology , Cross Infection/immunology , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/immunology , Immunocompromised Host , Intensive Care Units, Pediatric , Retrospective Studies , Risk Factors
3.
Rev. colomb. biotecnol ; 11(2): 57-65, dic. 2009.
Article in Spanish | LILACS | ID: lil-550520

ABSTRACT

Las cefotaximasas (CTX-M) son las beta-lactamasas de espectro extendido más ampliamente diseminadas entre especies de la familia Enterobacteriaceae, y son la causa principal de resistencia en aislamientos causantes de infección intrahospitalaria. El objetivo del presente trabajo fue identificar variantes de cefotaximasas del grupo CTX-M-1 mediante el análisis del polimorfismo conformacional de cadena sencilla (SSCP) de frag-mentos de restricción provenientes de los productos de la amplificación por PCR de los genes blaCTX-M. Con el procedimiento PCR-SSCP estandarizado, en este trabajo se analizaron 49 aislamientos de enterobacterias recolectados en 8 hospitales de Bogotá, D.C., adscritos a la Secretaría Distrital de Salud. Se detectaron las variantes CTX-M-12, CTX-M-15, CTX-M-12a, y CTX-M-1 y una nueva variante denominada CTX-M-60. Todas las variantes fueron detectadas tanto en aislamientos intrahospitalarios como de la comunidad, lo que indica posible movilidad de estos genes desde y hacia los centros hospitalarios. Esta publicación constituye el primer reporte en Colombia de la variante CTXM-12a y la nueva variante evolutiva CTX-M-60.


CTX-M cefotaximases are the most widely distributed extended-spectrum beta-lactamases among Enterobacteriaceae and they are an important cause of microbial resistance in nosocomial infection-causing isolates. The object of this work was to identify group 1 CTX-M cefotaximase variants from PCR amplified blaCTX-M genes by single-stranded conformational polymorphism of restriction fragments (RF-SSCP). We analysed 49 Enterobacteria isolates using the RF-SSCP procedure standardised in this work; isolates were collected from eight hospitals attached to the Bogota Health Secretariat (Secretaría Distrital de Salud). CTX-M-12, CTX-M-15, CTX-M-12a and CTX-M-1 variants were detected as well as a new one, designated CTX-M-60. All variants were detected in hospital and community isolates thereby indicating these genes’ possible high mobility from and towards hospital centres. This study represents the first report in Colombia of CTXM-12a and of the new evolutionary variant: CTX-M-60.


Subject(s)
Cross Infection/immunology , Cross Infection/microbiology , Cross Infection/virology
4.
J. pediatr. (Rio J.) ; 81(1,supl): s59-s68, mar. 2005. tab
Article in Portuguese | LILACS | ID: lil-406272

ABSTRACT

OBJETIVO: Realizar revisão sobre os principais aspectos do desenvolvimento imunológico fetal, salientando a defesa de prematuros extremos contra patógenos bacterianos e descrevendo a situação atual de intervenções imunoterapêuticas para a prevenção de sepse hospitalar. FONTES DOS DADOS: Obtiveram-se, por meio de busca eletrônica, no banco de dados MEDLINE, artigos publicados nos últimos 15 anos referentes ao tema, e foram selecionados aqueles que trouxessem informações relevantes. SíNTESE DOS DADOS: A imunidade de prematuros extremos é deficiente devido à fragilidade da pele, à carência dos produtos de ativação do sistema complemento, ao menor pool de reserva de precursores de neutrófilos na medula óssea e à quimiotaxia, aderência, deformabilidade e atividade enzimática neutrofílicas reduzidas. Limitações adicionais são detectadas na citotoxicidade de células NK, na proliferação e produção de citocinas dos linfócitos T, na cooperação entre células T e B e na síntese de anticorpos pelos linfócitos B. Ainda não foram demonstrados benefícios definitivos de intervenções para incremento da função imunológica dessas crianças, tais como o uso de imunoglobulinas endovenosas e de fatores estimuladores de colônias mielóides. CONCLUSAO: Em conseqüência à imaturidade de diversos componentes da imunidade, prematuros extremos são altamente suscetíveis a infecções nosocomiais. As possibilidades ainda muito limitadas para a intervenção nesse sistema fazem com que o controle dos fatores extrínsecos sejam essenciais para a prevenção da sepse nosocomial nessas crianças.


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Cross Infection/prevention & control , Infant, Premature/immunology , Infant, Very Low Birth Weight/immunology , Sepsis/prevention & control , Cross Infection/immunology , Fetus/immunology , Sepsis/immunology
5.
São Paulo; s.n; 2002. 155 p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-313792

ABSTRACT

O isolamento de cepas de Staphylococcus aureus resistente à vancomicina (VRSA) de amostras clínicas foi rekatado no Japão, França, Estados Unidos e Coréia, mas ainda não havia sido relatado no Brasil. O objetivo deste estudo foi avaliar a possível presença de cepas hetero-VRSA ou VRSA em 05 hospitais públicos da cidade de São Paulo. No total, foram triadas 469 cepas de S aureus resistentes à oxacilina (ORSA), das quais 198 foram isoladas no Hospital Geral de Vila Penteado (HGVP), 137 no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), 50 no Hospital AC Camargo, 48 no Hospital Emílio Ribas e 36 no Hospital Universitário da USP. A triagem das cepas hetero-VRSA e VRSA foi realizada...


Subject(s)
Humans , Anti-Bacterial Agents , Antibodies, Bacterial/pharmacology , Antibodies, Bacterial/immunology , DNA, Bacterial , Glycopeptides , In Vitro Techniques , Cross Infection/epidemiology , Cross Infection/immunology , Cross Infection/microbiology , Microbiology , Vancomycin Resistance/immunology , Staphylococcus aureus , Bacterial Growth , Cell Culture Techniques , Electrophoresis, Gel, Pulsed-Field , Polymerase Chain Reaction , Cell Separation/methods , Specimen Handling
6.
Rev. mex. patol. clín ; 48(2): 70-77, abr.-jun. 2001. tab, CD-ROM
Article in Spanish | LILACS | ID: lil-310750

ABSTRACT

Objetivo: Determinar la utilidad de la detección de antígeno galactomanan mediante anticuerpos monoclonales, examen directo y cultivo en el rastreo y diagnóstico de aspergilosis nosocomial.Material y métodos: Se estudiaron niños hospitalizados en el Instituto Nacional de Pediatría, durante un brote de aspergilosis nosocomial en el periodo 1 de octubre de 1997 al 31 de julio de 1998. Las edades de los pacientes estuvieron comprendidas de 1 día a 18 años de edad, todos ellos con diagnóstico confirmado de aspergilosis, mediante el trabajo clínico, laboratorio y gabinete. Los pacientes se dividieron en dos grupos: Grupo A. Pacientes con aspergilosis nosocomial, diagnosticados mediante laboratorio (detección de antígeno, examen directo, cultivo) y gabinete. Grupo B. Pacientes con aspergilosis compatible por clínica, pero que fue descartada por laboratorio (detección de antígeno, examen directo, cultivo) y gabinete. El cálculo de la muestra se realizó de acuerdo con el estudio de Patterson con una p1: 60, p2:15, P ponderada de 0.365 y una Q ponderada de 0.625. En el estudio se incluyeron 16 pacientes positivos y 60 pacientes negativos.Resultados: La asociación entre el hongo y el cuadro clínico fue: A. flavus se encontró en 57.1 por ciento de los casos pulmonares, A. fumigatus, A. flavus y A. niger se encontraron en 33.3 por ciento de los casos de aspergilosis sinusal. Se consideró la detección de antígeno galactomanan como el estándar de oro en el diagnóstico de aspergilosis nosocomial; el examen directo tuvo sensibilidad de 0.31 y especificidad de 1.0, un valor predictivo positivo de 1.0 y un valor predictivo negativo de 0.87. El cultivo presentó sensibilidad de 0.54 y especificidad de 0.97, un valor predictivo positivo de 0.78 y un valor predictivo negativo de 0.91. Conclusión: La detección de antígeno galactomanan con anticuerpos monoclonales y el examen directo son las pruebas de laboratorio de mayor utilidad en el rastreo y diagnóstico de aspergilosis nosocomial. El cultivo es de utilidad para identificar la especie de hongo. Basados en los resultados del presente trabajo, posteriormente se detectaron otros 22 casos de aspergilosis nosocomial. En el trabajo aquí presentado la mortalidad fue de 37.5 por ciento comparada con el 50 por ciento a 94 por ciento publicado en otras series.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Adolescent , Aspergillosis , Antigens , Diagnosis , Cross Infection/immunology , Aspergillus , Antibodies, Monoclonal
7.
Bol. venez. infectol ; 10(1): 22-24, ene.-jul. 2000. tab
Article in Spanish | LILACS | ID: lil-721156

ABSTRACT

Se revisaron en forma retrospectiva las histórias clínicas de todos los pacientes en los cuales se aisló Hansenula anómala en los hemocultivos realizados en el Laboratorio de Microbiología del Hospital Privado Centro Médico de Caracas, en el lapso de 2 años y medio, comprendido entre agosto 1994 y febrero 1997. De 57 pacientes se obtuvo 64 hemocultivos positivos, aislándose 64 especies de Candida. Hansenula anómala se obtuvo en 15 hemocultivos de 15 pacientes diferentes, representando un 26,3 por ciento del total de pacientes, un 23,4 por ciento del total de las candidas y un 30,6 por ciento de las variedades no albicans. La Candida albicans se aisló en 15 pacientes (26,3 por ciento del total). De los pacientes que presentaron Hansenula anómala en sus hemocultivos, el 100 por ciento cumplieron con criterios clínicos de severidad. El rango de edad estaba comprendido entre 1 mes y 76 años, con una media de 43, de los cuales 6 eran masculinos y 9 femeninos. De este grupo de pacientes, 12 ingresaron con patología abdominal, siendo intervenidos quirúrgicamente 10 de estos. De los tres pacientes restantes, dos ameritaron cirugía no abdominal. Todos los pacientes recibieron antibióticos de amplio espectro, nutrición parenteral total y le fue colocado catéteres centrales. Nueve pacientes (60 por ciento) tuvieron criterios de sepsis. Los días de hospitalización oscilaron entre 7 y 101 días, con un promedio de 37. Doce pacientes ameritaron ingreso a la Unidad de Terapia Intensiva. Se inició Anfotericina B en 8 pacientes, con buena respuesta en el 100 por ciento. Seis pacientes recibieron como terapia inicial Fluconazol: 2 con respuesta satisfactoria; 1 fallecido no relacionado con la infección por Hansenula anómala y los tres restantes ameritaron cambio a Anfotericina B. Un paciente no recibió tratamiento antifúngico desconociéndose su evolución.


Subject(s)
Humans , Male , Adolescent , Adult , Female , Child, Preschool , Child , Middle Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Fluconazole/administration & dosage , Fungemia/complications , Fungemia/pathology , Cross Infection/immunology , Pichia/immunology , Pichia/isolation & purification , Candida/isolation & purification , Infectious Disease Medicine , Medical Records
8.
Indian J Pediatr ; 1996 Jul-Aug; 63(4): 517-21
Article in English | IMSEAR | ID: sea-80014

ABSTRACT

A total of 76 premature newborn infants with gestational age of 34 weeks or less were enrolled in a randomized controlled study to determine whether intravenously administrated immunoglobulin (IVIG) is able to prevent nosocomial sepsis. Forty infants were given 0.5 g/kg IVIG on the first day of life and 36 infants with similar gestational age and birth weight were selected as controls and did not receive IVIG. The frequency of proven sepsis, with a positive blood and/or cerebrospinal fluid culture, was significantly lower in infants who received IVIG as compared to controls (42.5 vs 80.0%) (p < 0.01). The mortality rate attributable to infection was not different in IVIG recipients and in controls (41 vs 48%) (p > 0.05). The overall mortality rates in the two groups were not different either (35.0 vs 44.4%) (p > 0.05). The majority of micro-organisms isolated from the blood culture of the patients were gram negative microorganisms (Klebsiella, Enterobacter). IVIG therapy was believed to be effective for prophylaxis of nosocomial infection, but such therapy was not able to reduce overall mortality rate or mortality rate due to systemic infection in prematurely born infants in our intensive care unit where the causative pathogens are usually gram negative microorganisms.


Subject(s)
Cross Infection/immunology , Female , Gestational Age , Hospital Mortality , Humans , Immunization, Passive , Infant, Newborn , Infant, Premature, Diseases/immunology , Male , Risk Factors , Treatment Outcome , Turkey
9.
Rev. Inst. Med. Trop. Säo Paulo ; 37(6): 483-7, nov.-dez. 1995. ilus, tab
Article in English | LILACS | ID: lil-165520

ABSTRACT

Leveduras do genero Candida tem sido reconhecidas como importantes causadoras de fungemias hospitalares. Foram estudados os DNA cromossomicos de oito cepas de C. albicans, obtidas de oitos pacientes com fungemia hospitalar, por cariotipagem eletroforetica atraves de "pulsed-field gel electrophoresis". As cepas foram obtidas pelo isolamento da levedura em seis hemoculturas e duas infeccoes relacionadas ao uso de cateter intra-venoso central. Foram identificados sete perfis de DNA cromossomico. Dois pacientes mostraram cepas com o mesmo perfil de DNA sugerindo transmissao nosocomial. A cariotipagem eletroforetica revelou excelente capacidade discriminatoria entre os isolados sendo util no estudo das candidemias hospitalares.


Subject(s)
Humans , Dermatomycoses/etiology , Cross Infection/blood , Models, Molecular , Candidiasis, Cutaneous/diagnosis , Cross Infection/immunology
12.
EJMM-Egyptian Journal of Medical Microbiology [The]. 1994; 3 (1): 173-179
in English | IMEMR | ID: emr-32284

ABSTRACT

This study included 60 patients from Kasr EI-Eini Hospital suffering from nosocomial urinary tract infection [UTI], 30 of them are diabetics and 30 are non diabetics, and also 20 normal controls. Urine counts and cultures are done to isolate the causative organisms and serum IgM and IgG levels are determined [as a parameter of humoral immunity]. Results of this study revealed that E. coli was the predominant isolate in both diabetics [80%] and non diabetics [70%] followed by Klebsiella [20% in both groups] Pseudomonas aeruginosa was isolated only from non diabetic group [10%]. Both groups showed statistically siginificant increased levels of IgG and IgM when compared to the control group. However, no statistically significant difference was found when both diabetic and non diabetic groups are compared


Subject(s)
Humans , Male , Urinary Tract Infections/immunology , Urinary Tract Infections/etiology , Cross Infection/immunology , Immunoglobulin G/blood , Immunoglobulin M/blood , Diabetes Mellitus/physiopathology
13.
Mem. Inst. Oswaldo Cruz ; 88(1): 135-40, jan.-mar. 1993. tab, ilus
Article in English | LILACS | ID: lil-117662

ABSTRACT

Nosocomial infections are a relevant factor in complicating the recovery of patients interned for even minor causes. In attempt to determine their origin it is crucial to consider that their origin is of an endogenous nature. Looking for an acessible expression of intestinal colonization we analyzed fecal samples from 3 separate groups of hospital patients collected after different lenghts of time. For practical reasons one group was studied prospectively and two other groups (patients hospitalized for up to 7 days and patients hospitalized for more than 7 days) were compared to one another. We looked for the emergence of tellurite resistance among Enterobacteriaceae using a selective medium. MacConkey potassium tellurite (MCPT). The frequence of prospectively studied patients with tellurite resistant strains was significantly greater after 7 days of hospitalization. For the two other groups, patients with more than 7 days of hospitalization showed a significant increase of bacterial species and of strains with new antimicrobial resistance markers. High molecular weigth plasmids were detected in some of these strains. These data show that the MCPT medium is a useful tool for the investigation of bowel colonization in hospitalized patients by drug-resistant Enterobacteriaceae


Subject(s)
Humans , Enterobacteriaceae/drug effects , Cross Infection/immunology , Drug Resistance , Brazil
14.
J. bras. med ; 61(2): 52, 54, 56, passim, ago. 1991. tab, graf
Article in Portuguese | LILACS | ID: lil-201514

ABSTRACT

Foi avaliada a resposta imunológica em 40 pacientes submetidos a cirugias eletivas limpas, comparando-se os resultados aos valores obtidos em 50 indivíduos sadios e a valores padröes. Os resultados mostraram diminuiçäo estatisticamente significativa da resposta imunológica nos pacientes que evoluíram para infecçäo intra-hospitalar. Os autores acreditam que esses dados possam iniciar uma linha de pesquisa visando identificar um grupo de indivíduos que, quando internados, apresentem maior risco de adquirir infecçäo hospitalar.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Cross Infection/immunology , Cross Infection/economics , Cross Infection/prevention & control , Postoperative Care , Preoperative Care , Risk Factors , Health Systems/organization & administration , Surgical Procedures, Operative
16.
Rev. paul. med ; 104(2): 87-92, mar.-abr. 1986.
Article in Portuguese | LILACS | ID: lil-34579

ABSTRACT

Bacteremia por bacilos gram-negativos permanece como a principal causa de morte em indivíduos imunossuprimidos. Fatores relacionados com a bactéria, o hospedeiro e com dados epidemiológicos säo discutidos neste artigo. Além destes, alguns aspectos da terapêutica, assim como do estágio inicial das pesquisas nesse campo, säo mostrados


Subject(s)
Humans , Immunosuppression Therapy , Sepsis/immunology , Cross Infection/immunology , Sepsis/physiopathology , Sepsis/therapy , Aminoglycosides/therapeutic use , Immunotherapy , Anti-Bacterial Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL